Lymphoproliferative disorders

Jump to: navigation, search
Lymphoproliferative disorders
ICD-9 238.79
eMedicine ped/1345 
MeSH D008232

WikiDoc Resources for Lymphoproliferative disorders

Articles

Most recent articles on Lymphoproliferative disorders

Most cited articles on Lymphoproliferative disorders

Review articles on Lymphoproliferative disorders

Articles on Lymphoproliferative disorders in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lymphoproliferative disorders

Images of Lymphoproliferative disorders

Photos of Lymphoproliferative disorders

Podcasts & MP3s on Lymphoproliferative disorders

Videos on Lymphoproliferative disorders

Evidence Based Medicine

Cochrane Collaboration on Lymphoproliferative disorders

Bandolier on Lymphoproliferative disorders

TRIP on Lymphoproliferative disorders

Clinical Trials

Ongoing Trials on Lymphoproliferative disorders at Clinical Trials.gov

Trial results on Lymphoproliferative disorders

Clinical Trials on Lymphoproliferative disorders at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lymphoproliferative disorders

NICE Guidance on Lymphoproliferative disorders

NHS PRODIGY Guidance

FDA on Lymphoproliferative disorders

CDC on Lymphoproliferative disorders

Books

Books on Lymphoproliferative disorders

News

Lymphoproliferative disorders in the news

Be alerted to news on Lymphoproliferative disorders

News trends on Lymphoproliferative disorders

Commentary

Blogs on Lymphoproliferative disorders

Definitions

Definitions of Lymphoproliferative disorders

Patient Resources / Community

Patient resources on Lymphoproliferative disorders

Discussion groups on Lymphoproliferative disorders

Patient Handouts on Lymphoproliferative disorders

Directions to Hospitals Treating Lymphoproliferative disorders

Risk calculators and risk factors for Lymphoproliferative disorders

Healthcare Provider Resources

Symptoms of Lymphoproliferative disorders

Causes & Risk Factors for Lymphoproliferative disorders

Diagnostic studies for Lymphoproliferative disorders

Treatment of Lymphoproliferative disorders

Continuing Medical Education (CME)

CME Programs on Lymphoproliferative disorders

International

Lymphoproliferative disorders en Espanol

Lymphoproliferative disorders en Francais

Business

Lymphoproliferative disorders in the Marketplace

Patents on Lymphoproliferative disorders

Experimental / Informatics

List of terms related to Lymphoproliferative disorders

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Keywords: B cell proliferation, T cell proliferation, LPD, lymphoproliferation, lymphoproliferative neoplasm

Overview

Lymphoproliferative disorders refer to several conditions in which lymphocytes are produced in excessive quantities. They typically occur in patients who have compromised immune systems. They are sometimes equated with "immunoproliferative disorders", but technically lymphoproliferative disorders are a subset of immunoproliferative disorders, along with hypergammaglobulinemia and paraproteinemias.

Examples of LPDs

Types

Lymphoproliferative disorders are a set of disorders characterized by the abnormal proliferation of lymphocytes into a monoclonal lymphocytosis. The two major types of lymphocytes are B cells and T cells, which are derived from pleuripotent hematopoetic stem cells in the bone marrow. Individuals who have some sort of immunodysfuction are susceptible to developing a lymphoproliferative disorder because when any of the numerous control points of the immune system become dysfunctional, immunodeficiency or deregulation of lymphocytes is more likely to occur. There are several inherited gene mutations that have been identified to cause lymphoproliferative disorders, however there are also acquired and iatrogenic causes.[1]

X-linked Lymphoproliferative disorder

There is a mutation on the X chromosome that has been found to be associated with a T and NK cell lymphoproliferative disorder.

Autosomal lymphoproliferative disorder

Some children with autoimmune lymphoproliferative disorders are heterozygous for a mutation in the gene that codes for the Fas receptor, which is located on the long arm of chromosome 10 at position 24.1, denoted 10q24.1.[2] This gene is member 6 of the TNF-receptor superfamily (TNFSF6). The Fas receptor contains a death domain and has been shown to play a central role in the physiological regulation of programmed cell death. Normally, stimulation of recently activated T cells by antigen leads to coexpression of Fas and Fas receptor on the T cell surface. The engagement of Fas by Fas receptor results in apoptosis of the cell and is important for eliminating T cells that are repeatedly stimulated by antigens.[3] As a result of the mutation in the Fas receptor gene, there is no recognition of Fas by Fas receptor, leading to a primitive population of T cells that proliferates in an uncontrolled manner.[1]

Other inherited causes

Boys with X-linked immunodeficiency syndrome are at a higher risk of mortality associated with EBV infections, and are predisposed to develop a lymphoproliferative disorder or lymphoma.

Children with common variable immune deficiency (CVID) are also at a higher risk of developing a lymphoproliferative disorder.

Some disorders that predispose a person to lymphoproliferative disorders are severe combined immuno deficiency (SCID), Chédiak-Higashi syndrome, Wiskott-Aldrich syndrome (an X-linked recessive disorder) and Ataxia telangiectasia.

Interestingly, even though Ataxia telangiectasia is an autosomal recessive disorder, people who are heterozygotes for this still have an increased risk of developing a lymphoproliferative disorder.[1]

Acquired causes

Viral infection is a very common cause of lymphoproliferative disorders. The most common is congenital HIV infection because it is highly associated with acquired immunodeficiency, which often leads to lymphoproliferative disorders.[1]

Iatrogenic causes

There are many lymphoproliferative disorders that are associated with organ transplantation and immunosuppressant therapies. In most reported cases, these cause B cell lymphoproliferative disorders, however some T cell variations have been described.[1] The T cell variations are usually caused by the prolonged use of T cell suppressant drugs, such as sirolimus, tacrolimus belatacept or cyclosporine A.[1]

See also

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Winter, S.S. Lymphoproliferative disorders. Emedicine. December 20, 2006. http://www.emedicine.com/ped/topic1345.htm. Accessed March 2007.
  2. Entrez Gene. FAS Fas (TNF receptor superfamily, member 6). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=gene&dopt=full_report&list_uids=355. Accessed March 2007.
  3. Abbas, A.K and Lichtman, A.H. Cellular and Molecular Immunology. Fifth Edition. Elsevier Saunders. Philadelphia. 2005

External links


ar:مرض التكاثر الليمفاوي


Linked-in.jpg